Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumours × capivasertib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumour 1 Advanced Solid Tumours 1 Advanced Solid Malignancy 1

Interventions

adavosertib 4 Paclitaxel 3 pembrolizumab 2 olaparib 2 durvalumab 2 ceralasertib 2 Fluorouracil 2 Carboplatin 2 sintilimab 1 factor IX, factor VII, factor X, prothrombin drug combination 1 drug XX Z 1 danvatirsen 1 capivasertib 1 Rifampin 1 Pantoprazole 1 Omeprazole 1 Leucovorin 1 Itraconazole 1 Irinotecan 1 Injections 1 Gemcitabine 1 Doxorubicin 1 Cisplatin 1 AZD0156 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04742036 2022-08-19

Capivasertib China PK Study

AstraZeneca

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡